MedTrace Logo

Low-dose GH Supplementation Increases Clinical Pregnancy Rate

NCT02359695 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2017-05-10

No results posted yet for this study

Summary

The objective of this study is to assess whether a low dose of GH supplementation (0.5 IU/day) increases clinical pregnancy rates in women with a history of POR who failed to become pregnant in two previous IVF cycles.

Conditions

Interventions

DRUG

Growth Hormone

A dose of 0.5 IU of growth hormone will be administered daily from the first day of the agonist until the day of hCG administration

Sponsors & Collaborators

  • Centro de Infertilidad y Reproducción Humana

    lead OTHER

Principal Investigators

  • Mario Brassesco, MD · Centro de Infertilidad y Reproducción Humana

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-12-31
Completion
2017-05-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02359695 on ClinicalTrials.gov